Wearable Cardiac Devices Market Size – By Product, By Application, By End Use, Forecast, 2025-2034

Wearable Cardiac Devices Market Size

The global wearable cardiac devices market size was valued at USD 2.4 billion in 2024 and is estimated to grow at 12% CAGR from 2025 to 2034. Wearable cardiac devices are portable medical devices that are meant for everyday use by patients for managing their heart health and wellbeing. Based on one’s behavioral as well as psychological functions such as heart rhythm, heart rate, physical activity, and sleep, these devices can collect, store and analyze long-term data; this allows doctors to monitor the health condition of their patients remotely avoiding the traditional clinical visit settings. Most of these devices include a receptor and a transducer.
 

The increasing prevalence of cardiovascular diseases (CVD) worldwide is propelling the market growth. For instance, according to the estimates from the World Heart Federation, cardiovascular diseases are one of the leading causes of mortality worldwide and a major contributor to disability.
 

In 2021, CVD were responsible for 20.5 million deaths. This number accounts for one third of all the deaths across the globe. Thus, there is an urgent need for advanced monitoring solutions, such as wearable cardiac devices, to ensure early detection as well as proper tracking of the condition, so patients can undertake the required treatments and start the process of cardiovascular health management. Such measures can contribute to improving patient outcomes and thereby the global burden of heart diseases can be reduced.
 

Furthermore, people are becoming more conscious about their heart health as well as taking preventive measures due to increasing awareness. These devices are being used as cardiac arrhythmia monitoring devices for individuals that are at greater risk, and remote management of patients that have had heart failure (HF) or peripheral artery disease (PAD), among other chronic cardiovascular illnesses.
 

 Wearable Cardiac Devices Market Trends

• Cardiovascular wearable devices which were earlier focused only on basic heart rate tracking, have now evolved to include certain advanced technologies. For instance, galvanic contact records the differences on the skin, which enables measurement of ECG and HR, and detects the change in thoracic impedance to obtain the respiration rate and lung fluid.
   
• Moreover, photoplethysmography (PPG) measures blood volume changes in different tissues, enabling the calculation of cardiovascular parameters such as HR, heart rate variability, blood pressure (BP), stroke volume, and oxygen saturation in the blood (SPO2).
   
• Further, radio frequency (RF) waves achieve this by measuring parameters such as HR, BP, respiration rate, and the lung fluid, then breaking the signal down into waves which are distorted by the organs.
   
• In addition, the advanced features that are being incorporated into the wearable cardiac devices include ECG monitoring, blood pressure tracking, heart rate tracking, thoracic fluid index, and integration of artificial intelligence (AI) and machine learning (ML).
   
• Moreover, non-invasive techniques such as cuff-less blood pressure monitoring and continuous oxygen saturation tracking has broadened the scope of wearables for patients with hypertension and chronic heart ailments. Such sophisticated technologies are propelling market expansion.
   

Wearable Cardiac Devices Market Analysis

Based on product, the market is segmented into holter monitors, smartwatches, patch, defibrillators, pulse oximeters, and other products. The smartwatches segment dominated the wearable cardiac devices market accounting for 28.2% of revenue share in 2024.
 

• Smartwatches designs are simple which allow users to track their cardiac health without the necessity of professionals. enhancing accessibility for a wide range of consumers.
   
• In addition, these watches are equipped with sensors and AI, which enable real-time monitoring for the user as well as the healthcare providers to facilitate decision-making regarding heart issues.
   
• Furthermore, advanced algorithms identify abnormal heart rhythms such as atrial fibrillation which can help in reducing the chances of any critical events. Moreover, as smartwatches track a variety of vital signs, including heart rate, ECG, blood oxygen levels, and activity levels, users get a complete view of their cardiovascular health.
   
• For instance, CardiacSense watch monitors heart rate and can detect atrial fibrillation as well. Additionally, the company plans to add features such as monitoring of vital signs including continuous respiratory rate, oxygen saturation, core temperature, and absolute blood pressure in near future.
   
• Thus, advanced features, compact designs and efforts of the key players to further improve their product are boosting the expansion of this segment in the market.
  
   
  

Based on application, the wearable cardiac devices market is bifurcated into coronary artery disease (CAD), cardiomyopathies, post-myocardial infarction, congenital heart diseases, post-surgical cardiac care, and other applications. The coronary artery disease segment accounted for a 37.4% market share in 2024 and is projected for significant growth to reach USD 2.9 billion by 2034.
 

• Coronary artery diseases (CADs) is the most prevalent type of heart disease. According to data from the Centers for Disease Control and Prevention (CDC), in 2022, 371,506 people died from CADs in the U.S.
   
• Moreover, lifestyle issues such as obesity, physical inactivity, unhealthy eating habits, and smoking tobacco are risk factors for developing CAD; and as these factors are increasing, the segment is witnessing growth, further propelling the market by generating demand for wearable cardiac devices.
   
• For instance, according to the estimates from the World Health Organization (WHO), in 2022, 1 in 8 people were obese globally. Moreover, adult obesity has increased more than two times since 1990, and adolescent obesity has quadrupled.
   
• Thus, increasing unhealthy lifestyle is a major contributor in the dominance of this segment which is projected to remain dominant in the forecast period as well.
   

Based on end use, the wearable cardiac devices market is bifurcated into hospitals, specialty centers, home care settings, and other end users. The home care settings segment accounted for a 35.4% market share in 2024.
 

• In home care settings, patients can use wearable cardiac devices without having to step out of their homes and visit a medical facility. Thus, they have a comfortable and familiar environment where their cardiac health can be continually monitored.
   
• Moreover, wearable cardiac devices align with the regulatory criteria, to offer appropriate devices for point-of-care (POC) settings.
   
• For instance, the World Health Organization’s ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid, robust, Equipment-free, and Deliverable to end-users) criteria necessitates the key players to follow the guidelines and make a comfortable product for the end-users.
   
• Thus, the ease of usage and devices made within regulatory guidelines are the factors stimulating the revenue expansion of this segment in the market
  .
   
  

The U.S. wearable cardiac devices market is projected to grow significantly, reaching USD 2.7 billion by 2034.
 

• The U.S. has a high prevalence of cardiac diseases, which is boosting the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in most ethnic groups, cardiovascular diseases are the leading cause of deaths in the U.S. In 2022, 702,880 people died from cardiac diseases.
   
• Moreover, the U.S. has a highly developed healthcare system with well-equipped medical infrastructure, thus promoting the use of wearable cardiac devices by patients.
   

Europe: The wearable cardiac devices market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The UK has a well-established regulatory environment, with bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) ensuring the safety and effectiveness of medical devices. Thus, companies can launch wearable cardiac devices to market with confidence, which in turn fosters innovation and product adoption.
   
• Moreover, the cardiac diseases in the country are on the rise. According to British Heart Foundation, there are more than 7.6 million people living with a heart disease in the UK.
   
• Thus, the aforementioned factors are expected to fuel the market growth in the country.
   

Asia Pacific: Japan wearable cardiac devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan has one of the world’s oldest populations, along with a high prevalence of cardiovascular diseases. For instance, according to Statista, in 2022, people over 65 years of age accounted for 29.3% of total Japanese population and this number is expected to rise to 38% by 2070, owing to low birth rate. Moreover, as per the data from National Center for Biotechnology Information, in recent years, the crude mortality rate of heart disease in Japan has been observed to rise year by year with the aging population.
   
• Furthermore, Japan’s healthcare system creates increased awareness of heart disease prevention and promotes early detection, the wearable cardiac devices, are becoming quite popular among consumers seeking to actively monitor their cardiovascular health.
   

Middle East and Africa: The wearable cardiac devices market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• In addition, the Saudi Arabia, Vision 2030 program plans to improve healthcare systems and increase access to more advanced medical technologies, ensuring effective service delivery.
• This shift towards modernized healthcare systems is promoting adoption of these devices by patients at risk for cardiovascular diseases, thus, expanding the country’s market.
   

 Wearable Cardiac Devices Market Share

The market for wearable cardiac devices is extremely fragmented with both existing companies and new participants pursuing product innovation and differentiation. The top five players holding majority of the share of approximately 40% are Medtronic, Philips Healthcare, Abbott Laboratories, iRhythm Technologies, and Boston Scientific. These firms use their expertise, strong distribution networks, and strategic business alliances to maintain a larger share of the market. They are building more sophisticated wearable devices with artificial intelligence and machine learning features integrated into them.
 

For instance, Zio XT by iRhythm Technologies is a continuous cardiac monitoring patch that uses AI to detect arrhythmias, which is aiding doctors to get insights for diagnosis as well as treatment. The device provides up to 14 days of continuous monitoring and is used for conditions such as atrial fibrillation.
 

In addition, manufacturers are partnering with medical institutions, to promote the adoption of their products which is further driving growth of the market. These partnerships aid in accelerating product development, enhancing patient care, and facilitating expansion into new markets. Moreover, the competition in the market is strengthened due to the government initiatives and policies that are favourable and promote more innovations.
 

 Wearable Cardiac Devices Market Companies

Some of the eminent market participants operating in the wearable cardiac devices industry include:

• Abbott Laboratories
• Boston Scientific
• Cardiac Insight
• CardiacSense
• Cardiac Rhythm
• iRhythm Technologies
• Integra LifeSciences
• Koninklijke Philips
• Medtronic
• Proteus Digital Health
• Qardio
• ZOLL Medical Corporation
• Welch Allyn
• VitalConnect
• Zimmer Biomet
   

• Medtronic utilizes technology as an effective tool for patient monitoring and therapy by providing a wide array of cardiac devices that are wearable.
   
• Boston Scientific specializes in cutting-edge wearable solutions which provides remote monitoring of heart failure patients.
   

Wearable Cardiac Devices Industry News:

• In January 2023, CardiacSense Ltd. received FDA clearance for its CSF-3 watch that measures ECG, heart rate, and SpO2. This enhanced the company's position in the market of wearable cardiac devices.
   
• In September 2023, iRhythm Technologies, Inc. launched its next-generation Zio monitor in the U.S. It is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. This launch improved patient and healthcare professional experiences, thereby promoting market growth.
   
• In January 2021, Philips acquired BioTelemetry and its wearable remote heart monitors, enhancing its portfolio in remote patient monitoring devices, which is expected to reach USD 41.3 billion in 2032. This acquisition enabled the company to provide monitoring solutions for heart health and strengthened its position in the digital health sector.
   
• In January 2021, Boston Scientific announced an agreement to acquire Preventice Solutions, Inc., a privately held firm offering products such as portable cardiac health solutions, including Holter monitors to mobile cardiac telemetry. This acquisition established the company in a strong position in the ambulatory electrocardiography space.
   

The wearable cardiac devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Holter monitors
• Smartwatches
• Patch
• Defibrillators
• Pulse oximeters
• Other products

Market, By Application

• Coronary artery disease (CAD)
• Cardiomyopathies
• Post-myocardial infarction
• Congenital heart diseases
• Post-surgical cardiac care
• Other applications

Market, By End Use

• Hospitals
• Specialty centers
• Home care settings
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE